Rheumatology
Showing page 1 of 6 pages of list content
-
Does Biological Therapy Protect against Severe COVID-19?
This article's authors -
Clinical Outcomes of Patients with COVID-19 and Chronic Inflammatory and Autoimmune Rheumatic Diseases: A Multicentric Matched-Cohort Study
This article's authors -
A COVID-19 outbreak in a rheumatology department upon the early days of the pandemic
This article's authors -
Hospital admissions in inflammatory rheumatic diseases during the COVID-19 pandemic: incidence and role of disease modifying agents
This article's authors -
Concerns about disease management and psychological stress in SAPHO patients during the COVID-19 epidemic
This article's authors -
COVID-19 AND PATIENTS UNDERGOING PHARMACOLOGICAL TREATMENTS FOR IMMUNE-MEDIATED INFLAMMATORY DISEASES: PROTOCOL FOR A RAPID LIVING SYSTEMATIC REVIEW
This article's authors -
Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs
This article's authors -
Safety of hydroxychloroquine, alone and in combination with azithromycin, in light of rapid wide-spread use for COVID-19: a multinational, network cohort and self-controlled case series study
This article's authors -
Management of rheumatic diseases in the times of COVID-19 pandemic- perspectives of rheumatology practitioners from India
This article's authors -
Epigenetic dysregulation ofACE2and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients
This article's authors